TRACE Study
-
Transfer of multivirus-specific T cells following transplantation: TRACE Study
The “TRACE” project is a multi-national project (Belgium, France, Germany, Italy, the Netherlands, UK) and is coordinated by the LMU Munich, Germany. The overall objective of the TRACE project is to bring Adoptive Transfer of virus-specific T cells into clinical routine, thereby facilitating that every single patient in Europe will have the possibility to receive this curative treatment.
This project is funded by the European Commission within Horizon2020 Framework Programme.
For more details see:
-
The Consortium consists of Partners from Basic, clinical and industrial Research and GMP-facilities (Good Manufacturing Practice laboratory), with proven qualification and leading Expertise in the field of HSCT (Haematopoietic Stem Cell Transplantation), GMP-manufacturing and adoptive T-cell tansfer. Impact and Exploration will reach beyond refractory viral infections post HSCT.
- Ludwig Maximilians University, LMU, Munich, Germany
Dr. von Hauner Children's Hospital (Coordinator) - Ospedale Pediatrico Bambino Gesù, OPBG, Rome, Italy
- Leiden University Medical Centre, LUMC, Leiden, The Netherlands
- Centre Hospitalier Universitaire de Nancy, CHU, Vandoeuvre-Lès-Nancy, France
- Newcastle University, UNEW, Newcastle, United Kingdom
- Ghent University Hospital, UZG, Ghent, Belgium
- Miltenyi Biotec GmbH, MILTENYI, Bergisch-Gladbach, Germany
- Simbec-Orion Group Ltd, ORION, Mid Glamorgan, United Kingdom
- Ludwig Maximilians University, LMU, Munich, Germany
-
TRACE Study
Coordinator: Prof. Dr. med. Tobias Feuchtinger Project Management: Dr. Theresa Kaeuferle Dr. von Hauner Children's Hospital, University Hospital LMU Munich
Lindwurmstrasse 4
80337 MunichluwüDbpgyiGcSbfamјemWiWebsite